Paul Cathcart
Overview
Explore the profile of Paul Cathcart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
776
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Preisser F, Incesu R, Rajwa P, Chlosta M, Nohe F, Ahmed M, et al.
Prostate Cancer Prostatic Dis
. 2023 Oct;
27(4):686-692.
PMID: 37803241
Background And Objective: Persistent prostatic specific antigen (PSA) represents a poor prognostic factor for recurrence after radical prostatectomy (RP). However, the impact of persistent PSA on oncologic outcomes in patients...
2.
Marra G, Calleris G, Conte F, Benfant N, Rajwa P, Ahmed M, et al.
Eur Urol Focus
. 2023 Sep;
10(3):461-468.
PMID: 37704503
Background: Salvage radical prostatectomy (sRP) yields poor functional outcomes and relatively high complication rates. Gleason score (GS) 6 prostate cancer (PCa) has genetic and clinical features showing little, if not...
3.
Preisser F, Incesu R, Rajwa P, Chlosta M, Ahmed M, Abreu A, et al.
Cancers (Basel)
. 2023 Jun;
15(12).
PMID: 37370733
Background: Lymph node invasion (LNI) represents a poor prognostic factor after primary radical prostatectomy (RP) for prostate cancer (PCa). However, the impact of LNI on oncologic outcomes in salvage radical...
4.
Sujenthiran A, Parry M, Dodkins J, Nossiter J, Morris M, Berry B, et al.
Clin Transl Radiat Oncol
. 2023 May;
40:100622.
PMID: 37152844
Purpose There is debate about the effectiveness and toxicity of pelvic lymph node (PLN) irradiation in addition to prostate bed radiotherapy when used to treat disease recurrence following radical prostatectomy....
5.
Saghir R, Russell B, Kum F, Darwish R, Deane J, Allen C, et al.
BJUI Compass
. 2023 Apr;
4(3):352-360.
PMID: 37025469
Introduction: A prospective cohort study comparing peri- and postoperative outcomes for patients with predominantly anterior prostate cancer (APC) identified preoperatively against non-anterior prostate cancer (NAPC) treated via robotic-assisted radical prostatectomy...
6.
Fanshawe J, Wai-Shun Chan V, Asif A, Ng A, Van Hemelrijck M, Cathcart P, et al.
Eur Urol Oncol
. 2023 Mar;
6(5):456-466.
PMID: 36870852
Context: Treatment choice for localised prostate cancer remains a significant challenge for patients and clinicians, with uncertainty over decisions potentially leading to conflict and regret. There is a need to...
7.
Calleris G, Marra G, Benfant N, Rajwa P, Ahmed M, Abreu A, et al.
Eur Urol Focus
. 2023 Jan;
9(4):645-649.
PMID: 36682962
Salvage radical prostatectomy (sRP) is a potentially curative option for locally radiorecurrent prostate cancer (PCa) but is associated with significant morbidity. Therefore, the European Association of Urology (EAU) guidelines recommend...
8.
Monroy-Iglesias M, Rai S, Mistretta F, Roberts G, Dickinson H, Russell B, et al.
BJUI Compass
. 2022 Jul;
3(4):277-286.
PMID: 35783588
Objective: To report on the outcomes of urological cancer patients undergoing radical surgery between March-September 2020 (compared with 2019) in the European Institute of Oncology (IEO) in Milan and the...
9.
Singhal U, Skolarus T, Gore J, Parry M, Chen R, Nossiter J, et al.
Nat Rev Urol
. 2022 Mar;
19(5):263-279.
PMID: 35260844
Measuring treatment-related quality of life (QOL) has become an increasingly requisite component of delivering high-quality care for patients with prostate cancer. Patient-reported outcome measures (PROMs) have, therefore, become an important...
10.
Nossiter J, Morris M, Parry M, Sujenthiran A, Cathcart P, van der Meulen J, et al.
BJU Int
. 2022 Jan;
130(2):262-270.
PMID: 35080142
Objective: To determine the impact of the COVID-19 pandemic on diagnostic and treatment activity in 2020 across hospital providers of prostate cancer (PCa) care in the English National Health Service....